Your browser doesn't support javascript.
loading
Selinexor population pharmacokinetic and exposure-response analyses to support dose optimization in patients with diffuse large B-cell lymphoma.
Xu, Hongmei; Li, Hanbin; Wada, Russ; Bader, Justin C; Tang, Shijie; Shah, Jatin; Shacham, Sharon.
Affiliation
  • Xu H; Karyopharm Therapeutics, 85 Wells Avenue, Suite 210, Newton, MA, 02459, USA. hxu@karyopharm.com.
  • Li H; Certara, Menlo Park, CA, USA.
  • Wada R; Certara, Menlo Park, CA, USA.
  • Bader JC; Karyopharm Therapeutics, 85 Wells Avenue, Suite 210, Newton, MA, 02459, USA.
  • Tang S; Karyopharm Therapeutics, 85 Wells Avenue, Suite 210, Newton, MA, 02459, USA.
  • Shah J; Karyopharm Therapeutics, 85 Wells Avenue, Suite 210, Newton, MA, 02459, USA.
  • Shacham S; Karyopharm Therapeutics, 85 Wells Avenue, Suite 210, Newton, MA, 02459, USA.
Cancer Chemother Pharmacol ; 88(1): 69-79, 2021 07.
Article in En | MEDLINE | ID: mdl-33770229
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Triazoles / Lymphoma, Large B-Cell, Diffuse / Hydrazines Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Triazoles / Lymphoma, Large B-Cell, Diffuse / Hydrazines Limits: Adolescent / Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: Cancer Chemother Pharmacol Year: 2021 Type: Article Affiliation country: United States